NIH-funded research NIH-funded research

Improving cancer research through advanced data analysis and biostatistics

Official title: Biostatistics/Computational Core

Funded at Dana-Farber Cancer Inst · NIH-10916206 · Data updated 2026-11-12

This study is all about improving cancer research by using smart data analysis and expert support to help turn lab discoveries into real treatments that can help patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDana-Farber Cancer Inst
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$168,184
NIH project number5P50CA272390-02
Project IDNIH-10916206 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals involved in ongoing cancer studies or those receiving treatment at the Dana-Farber Cancer Institute.

Less likely to help

Patients not involved in cancer research or treatment at this institution may not receive direct benefits from this research.

What this research studies

This research focuses on enhancing cancer studies by providing expert biostatistical and computational support. It aims to ensure rigorous study design, data management, and analysis across various cancer-related projects. By collaborating with multiple research programs, the core seeks to translate laboratory discoveries into clinical applications that can benefit patients. The methodology includes comprehensive data collection, integrity checks, and the use of advanced statistical software to analyze outcomes effectively.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatment strategies and better patient outcomes through more reliable data analysis.

How similar studies have gone: Previous research has shown success in utilizing biostatistics and computational methods to enhance cancer research outcomes, indicating that this approach is both tested and effective.

Where this research is happening

  • Dana-Farber Cancer Inst
    Boston, United States
    Active

Researchers

  • Principal investigator: Tyekucheva, Svitlana — Dana-Farber Cancer Inst
  • Study coordinator: Tyekucheva, Svitlana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.